title: Clinical characteristics of stroke patients with antiphospholipid antibodies.
abstract: BACKGROUND
  Antiphospholipid syndrome is important as a cause of ischemic stroke, although clinical characteristics of the syndrome are not well documented.
  
  
  METHODS
  We analyzed differences in clinical characteristics between 40 antiphospholipid-antibody (aPL)-positive and 40 aPL-negative stroke patients.
  
  
  RESULTS
  Stroke patients with aPL were significantly younger and were more likely to be women in comparison with stroke patients without aPL. Valvular heart disease, neurological complications and hematological disorders were more frequent in the aPL-positive group. The mean value of thrombin-antithrombin III complex was significantly lower in the aPL-positive group. Cerebral infarctions in the carotid system were less and large-artery lesions more frequent in the aPL-positive patients.
  
  
  CONCLUSIONS
  Stroke patients with aPL have clinical characteristics distinct from stroke patients without aPL.
authors.affiliation: Department of Neurology, Neurological Institute, Tokyo Women's Medical University School of Medicine, Tokyo, Japan. terashi@jb3.so-net.ne.jp
authors.forename: Hiromi
authors.initials: H
authors.lastname: Terashi
authors.forename: Shinichiro
authors.initials: S
authors.lastname: Uchiyama
authors.forename: Shiori
authors.initials: S
authors.lastname: Hashimoto
authors.forename: Kazuhide
authors.initials: K
authors.lastname: Miyazaki
authors.forename: Yukiko
authors.initials: Y
authors.lastname: Tsutsumi
authors.forename: Masako
authors.initials: M
authors.lastname: Yamazaki
authors.forename: Makoto
authors.initials: M
authors.lastname: Iwata
mesh_terms: D000208:Acute Disease; D000328:Adult; D000367:Age Factors; D000368:Aged; D017153:Antibodies, Anticardiolipin / Q000032:analysis; D017152:Antibodies, Antiphospholipid / Q000032:analysis*; D016736:Antiphospholipid Syndrome / Q000453:epidemiology / Q000276:immunology* / Q000503:physiopathology*; D015415:Biomarkers; D005260:Female; D006331:Heart Diseases / Q000150:complications / Q000453:epidemiology; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000453:epidemiology; D016682:Lupus Coagulation Inhibitor / Q000032:analysis; D008297:Male; D008875:Middle Aged; D009422:Nervous System Diseases / Q000453:epidemiology / Q000209:etiology; D012189:Retrospective Studies; D012307:Risk Factors; D012737:Sex Factors; D020521:Stroke / Q000453:epidemiology / Q000276:immunology* / Q000503:physiopathology*
chemical_list: D017153:Antibodies, Anticardiolipin; D017152:Antibodies, Antiphospholipid; D015415:Biomarkers; D016682:Lupus Coagulation Inhibitor